PTSM: Pharmaceutical Technology Sourcing and Management-11-02-2016

New catalysts show promise for pharmaceutical intermediate and API synthesis.

Covert and layered approaches to combat drug counterfeiting and illegal diversion strive to stay ahead of criminal enterprises.

Automation, single-use systems, smaller footprints, and new drug delivery devices define trends for fill/finish outsourcing.

Governments stretch limited resources to track counterfeit, diverted, and stolen pharmaceuticals globally. \

The Czech Republic drug manufacturer was cited for data integrity and quality issues.

GENCO, a FedEx Company, introduces a multi-tenant warehouse model in Milton, Ontario, and Memphis, Tennessee.

Catalent invests $34 million to add a 2 x 2000-L single-use bioreactor system and laboratory space in Madison, WI.

The researchers were awarded the Thomas Alva Edison Patent Award for a solventless method for coating APIs.

The new guidelines will address bioanalytical method validation and biopharmaceutics classification system-based biowaivers.

Recipharm announced that it has invested 5 million SEK in a new GLP bioanalysis laboratory in Uppsala.

CordenPharma announced the completion of a new highly potent process bay for APIs at the company’s Colorado facility.

Recipharm launched a showcase line to demonstrate the company’s new serialization solutions.

Marken announced the opening of a new depot and logistics operations center in Argentina.

A report from the European Union Intellectual Property Office shows that the EU loses approximately €10.2 billion a year due to counterfeit medicines.

Pharma Venture’s approach in tackling supply-chain, logistic, and distribution challenges in the MENA region was recognized at the CPhI Pharma Awards.

The Koolit Advanced PCM Gel from Cold Chain Technologies provides cold-temperature protection for drugs and vaccines during transport.

The company invested in a new cGMP facility located in Berlin, Germany.

he guidance addresses the good manufacturing practice for managing quality in APIs.

PaizaBio will add aseptic injectable production capacity in Hangzhou, China.